How Does the Canadian General Public Rate Moderate Alzheimer's Disease?

Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the healt...

Full description

Saved in:
Bibliographic Details
Main Authors: Jean-Eric Tarride, Mark Oremus, Eleanor Pullenayegum, Natasha Clayton, Parminder Raina
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Aging Research
Online Access:http://dx.doi.org/10.4061/2011/682470
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565312220823552
author Jean-Eric Tarride
Mark Oremus
Eleanor Pullenayegum
Natasha Clayton
Parminder Raina
author_facet Jean-Eric Tarride
Mark Oremus
Eleanor Pullenayegum
Natasha Clayton
Parminder Raina
author_sort Jean-Eric Tarride
collection DOAJ
description Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the health utility score for respondents' current health status (i.e., no AD) and for a hypothetical moderate AD health state. Regression analyses were conducted to explain the perceived utility decrement associated with AD. Results. The mean age of the respondents was 51 years, 60% were female, and 42% knew someone with AD. Respondents' mean EQ-5D scores for their current health status and a hypothetical moderate AD were 0.873 (SD: 0.138) and 0.638 (SD: 0.194), respectively (P<0.001). Age, gender, and education were significant factors explaining this decrement in utility. Conclusion. Members of the general public may serve as an alternative to patients and caregivers in the elicitation of health-related quality of life in AD.
format Article
id doaj-art-80acf887fb3c4b94b123d808734348ee
institution Kabale University
issn 2090-2212
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Journal of Aging Research
spelling doaj-art-80acf887fb3c4b94b123d808734348ee2025-02-03T01:08:06ZengWileyJournal of Aging Research2090-22122011-01-01201110.4061/2011/682470682470How Does the Canadian General Public Rate Moderate Alzheimer's Disease?Jean-Eric Tarride0Mark Oremus1Eleanor Pullenayegum2Natasha Clayton3Parminder Raina4Programs for Assessment of Technology in Health (PATH) Research Institute, St. Joseph's Healthcare Hamilton, 25 Main Street West, Suite 2000, Hamilton, ON, L8P 1H1, CanadaDepartment of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, CanadaDepartment of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, CanadaDepartment of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, CanadaDepartment of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, CanadaObjectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the health utility score for respondents' current health status (i.e., no AD) and for a hypothetical moderate AD health state. Regression analyses were conducted to explain the perceived utility decrement associated with AD. Results. The mean age of the respondents was 51 years, 60% were female, and 42% knew someone with AD. Respondents' mean EQ-5D scores for their current health status and a hypothetical moderate AD were 0.873 (SD: 0.138) and 0.638 (SD: 0.194), respectively (P<0.001). Age, gender, and education were significant factors explaining this decrement in utility. Conclusion. Members of the general public may serve as an alternative to patients and caregivers in the elicitation of health-related quality of life in AD.http://dx.doi.org/10.4061/2011/682470
spellingShingle Jean-Eric Tarride
Mark Oremus
Eleanor Pullenayegum
Natasha Clayton
Parminder Raina
How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
Journal of Aging Research
title How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_full How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_fullStr How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_full_unstemmed How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_short How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_sort how does the canadian general public rate moderate alzheimer s disease
url http://dx.doi.org/10.4061/2011/682470
work_keys_str_mv AT jeanerictarride howdoesthecanadiangeneralpublicratemoderatealzheimersdisease
AT markoremus howdoesthecanadiangeneralpublicratemoderatealzheimersdisease
AT eleanorpullenayegum howdoesthecanadiangeneralpublicratemoderatealzheimersdisease
AT natashaclayton howdoesthecanadiangeneralpublicratemoderatealzheimersdisease
AT parminderraina howdoesthecanadiangeneralpublicratemoderatealzheimersdisease